Coagulation Factor Deficiency in Dogs (Hypocoagulopathy)

  • Synonyms: Tendency to bleed
  • Occurrence: rarer
  • Location of disease: General/Whole body
Author: Dr. med. vet. Gisa Löwe | Last modified: 10.08.2026
Open table of contents

When to visit the vet?

Urgent see a veterinarian within 24 hours

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Coagulopathy due to deficiency of coagulation factors is a group of conditions caused by a deficiency or dysfunction of one or more proteins in the blood that are necessary for blood coagulation. This leads to an increased tendency to bleed.

Das Wichtigste auf einen Blick

Hypocoagulopathy in dogs is a blood coagulation disorder caused by a deficiency of coagulation factors. It can be either hereditary, such as hemophilia, or caused by external factors like vitamin K deficiency, liver diseases, or certain medications. Common symptoms include an increased tendency to bleed, delayed blood coagulation, bruising, and internal bleeding. Nosebleeds and mucosal bleeding can also occur, while in young animals, genetic factors often play a role. An accurate diagnosis is made through a detailed medical history, a clinical examination, and specific blood tests to identify deficiencies of individual coagulation factors. Treatment includes the substitution of missing coagulation factors, the administration of vitamin K in deficiency states, and the avoidance of medications that impair blood coagulation. The prognosis depends heavily on the type of coagulopathy and the availability of treatments. Research currently focuses on genetic causes, new treatment methods, and improved diagnostic procedures. Scientists are working to develop better screening methods and new therapies to directly address the underlying causes. Advances in genetics and medical technology offer hope for significant breakthroughs in the prevention and treatment of this complex disease.

Ursachen

  • Hereditary disorders such as hemophilia
  • Acquired conditions due to vitamin K deficiency, liver disease, or the use of certain medications
  • Secondary effects of other diseases

Symptoms

Rare symptoms:

Diagnose

  • Detailed medical history and clinical examination
  • Blood tests to measure coagulation factors and assess blood coagulation (PT, aPTT)
  • Specific tests to identify deficiencies of individual coagulation factors

Therapie

  • Replacement therapy with the missing coagulation factors
  • Administration of vitamin K in deficiency states
  • Avoidance of medications that may impair blood coagulation
  • Management and prevention of bleeding

Prognose und Nachsorge

  • The prognosis depends on the specific type of coagulopathy, the availability of treatments, and the ability to control bleeding. For some hereditary forms, lifelong treatment is required.

Ausblick auf aktuelle Forschung

Research on hypocoagulopathy in dogs currently focuses on various aspects, including genetic causes, the development of new treatment methods, and the improvement of diagnostic procedures. Scientists are investigating genetic predispositions that could make certain dog breeds more susceptible to this blood coagulation disorder. By identifying specific gene mutations, researchers hope to develop better screening methods to identify at-risk dogs early.

Another significant area of research is the development of therapies that specifically target deficiencies in coagulation factors. New medications and biological therapies are being tested to replace missing or defective coagulation factors in affected dogs. These treatments could soon offer an effective alternative to currently available therapy options, which often only alleviate symptoms instead of treating the underlying cause of the coagulopathy.

Researchers are also working on improving diagnostic techniques to enable early and precise detection of hypocoagulopathy. This includes the development of more sensitive blood tests and imaging procedures that can detect subtle changes in a dog’s blood coagulation system. More accurate diagnosis could help veterinarians better manage the condition and improve the quality of life for affected dogs.

Overall, research into hypocoagulopathy in dogs is a dynamic field that is constantly evolving. With advances in genetics and medical technology, there is justified hope that significant breakthroughs will be achieved in the coming years, which could revolutionize both the prevention and treatment of this complex disease.

Frequently Asked Questions (FAQs)

1. What is hypocoagulopathy in dogs?
Minus coagulopathy is a blood clotting disorder in dogs caused by a deficiency of certain coagulation factors. Affected dogs have difficulty stopping Bleeding, which can lead to excessive Bleeding even from minor injuries. -
2. What symptoms indicate hypocoagulopathy?
Common symptoms include spontaneous Bleeding, bruising, nosebleeds, bloody urine or stool, excessive Bleeding after surgery or injuries, and in female dogs prolonged or heavier heat. Some dogs may also develop anemia or weakness. -
3. What are the causes of hypocoagulopathy?
The causes can be genetic, with certain breeds having a higher predisposition. Acquired causes such as certain diseases, medications, or poisonings can also lead to a deficiency of coagulation factors. -
4. How is hypocoagulopathy diagnosed?
The diagnosis is usually made through a combination of clinical symptoms, blood tests that measure clotting ability, and, if necessary, genetic tests to determine an inherited predisposition. -
5. What treatment options are available?
Treatment depends on the cause and severity of the coagulopathy. It may include administering coagulation factors, hemostatic medications, blood transfusions, or treating underlying conditions. In some cases, dietary changes or supplements may be helpful. -
6. Is hypocoagulopathy curable?
A complete cure is currently not possible, especially if the condition is genetic. Treatment aims to control symptoms and improve the dog’s quality of life. -
7. Can all dog breeds be affected?
Yes, in theory all breeds can be affected, but certain breeds are more susceptible due to genetic predispositions. Examples include Dobermans and Cocker Spaniels, in which a higher incidence has been found. -
8. Are there preventive measures to avoid hypocoagulopathy?
There are currently no specific preventive measures for genetically caused forms. For acquired forms, it is important to minimize risk factors, such as avoiding certain medications or toxins and having regular veterinary check-ups. -
9. How does hypocoagulopathy affect a dog's daily life?
Dogs with this condition can live a normal life, but may need extra caution with physical activities to avoid injuries. Regular veterinary monitoring and tailored care are important to prevent complications. -
10. Can humans be infected by dogs with hypocoagulopathy?
No, minus coagulopathy is not contagious and cannot be transmitted from dogs to humans or other animals.

Literatur

  • Clark, J. A., Hooser, S. B., Dreger, D. L., Burcham, G. N., & Ekenstedt, K. J. (2022). Investigation of a common canine factor VII deficiency variant in dogs with unexplained bleeding on autopsy. Journal of Veterinary Diagnostic Investigation, 34(5), 806–812. https://doi.org/10.1177/10406387221118581
  • Ramirez, C. J., Krug, M., Zahand, A., Sundin, K., Shaffer, L. G., & Ballif, B. C. (2019). Canine factor VII deficiency: Lessons learned in applying methods-based laboratory proficiency testing. Journal of Veterinary Diagnostic Investigation, 31(2), 276–279. https://doi.org/10.1177/1040638718825281
  • Callan, M. B., Aljamali, M. N., Margaritis, P., Griot-Wenk, M. E., Pollak, E. S., Werner, P., Giger, U., & High, K. A. (2006). A novel missense mutation responsible for factor VII deficiency in research Beagle colonies. Journal of Thrombosis and Haemostasis, 4(12), 2616–2622. https://doi.org/10.1111/j.1538-7836.2006.02203.x
  • Aslanian, M. E., Sharp, C. R., Rozanski, E. A., de Laforcade, A. M., Rishniw, M., & Brooks, M. B. (2014). Clinical outcome after diagnosis of hemophilia A in dogs. Journal of the American Veterinary Medical Association, 245(6), 677–683. https://doi.org/10.2460/javma.245.6.677
  • Kong, L. R., Giger, U., McMichael, M. A., & O’Brien, R. T. (2014). Recurrent episodes of severe bleeding caused by factor XIII deficiency in a dog. Journal of Veterinary Internal Medicine, 28(6), 1858–1862. https://doi.org/10.1111/jvim.12428
  • Nichols, T. C., Raymer, R. A., Franck, H. W. G., Merricks, E. P., Bellinger, D. A., Defriess, N. A., Margaritis, P., Arruda, V. R., & High, K. A. (2010). Prevention of spontaneous bleeding in dogs with haemophilia A or haemophilia B. Haemophilia, 16(Suppl. 3), 19–23. https://doi.org/10.1111/j.1365-2516.2010.02251.x
  • Knudsen, T., Kjelgaard-Hansen, M., Tranholm, M., Kristensen, A. T., & Wiinberg, B. (2011). Canine specific ELISA for coagulation factor VII. Veterinary Clinical Pathology, 40(2), 212–218. https://doi.org/10.1111/j.1939-165X.2011.00316.x